Olaf Eickmeier
Impact in
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
-
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Tracheal and airway disorders
Papers in
-
- Cystic Fibrosis Research Advances 20
- Neonatal Respiratory Health Research 7
- Respiratory and Cough-Related Research 4
- Physiology 11
- Asthma and respiratory diseases 10
- Co-authors
- Stefan Zielen (31 shared papers)Ralf Schubert (20 shared papers)Martin Rosewich (7 shared papers)Sabina Schmitt‐Grohé (9 shared papers)Patrick C. Baer (5 shared papers)Eva Herrmann (5 shared papers)Christina Smaczny (10 shared papers)Ulrich M. Zissler (4 shared papers)
- Journals
- Journal of Cystic Fibrosis (5 papers)European Respiratory Journal (4 papers)Frontiers in Bioscience-Landmark (2 papers)Mucosal Immunology (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Olaf Eickmeier
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Immunology and Allergy 95
- Pulmonary and Respiratory Medicine 464
- Nutrition and Dietetics 130
- Immunology 156
- Biochemistry 54
Countries citing papers authored by Olaf Eickmeier
This map shows the geographic impact of Olaf Eickmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Eickmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Eickmeier more than expected).
Fields of papers citing papers by Olaf Eickmeier
This network shows the impact of papers produced by Olaf Eickmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Eickmeier. The network helps show where Olaf Eickmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Olaf Eickmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 158 | |
| 2 | 2010 | 110 | |
| 3 | 2013 | 61 | |
| 4 | 2022 | 55 | |
| 5 | 2010 | 52 | |
| 6 | 2017 | 52 | |
| 7 | 2017 | 50 | |
| 8 | 2011 | 47 | |
| 9 | 2017 | 42 | |
| 10 | 2002 | 33 | |
| 11 | 2016 | 32 | |
| 12 | 2008 | 31 | |
| 13 | 2011 | 27 | |
| 14 | 2020 | 24 | |
| 15 | 2013 | 19 | |
| 16 | 2021 | 19 | |
| 17 | 2024 | 19 | |
| 18 | 2014 | 17 | |
| 19 | 2019 | 17 | |
| 20 | 2013 | 17 |
About Olaf Eickmeier
Olaf Eickmeier is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Nutrition and Dietetics, Infectious Diseases and Immunology and Allergy, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (20 papers), Asthma and respiratory diseases (10 papers), Neonatal Respiratory Health Research (7 papers), Antifungal resistance and susceptibility (5 papers), Fatty Acid Research and Health (5 papers), Respiratory viral infections research (4 papers), Nematode management and characterization studies (4 papers) and Respiratory and Cough-Related Research (4 papers). The work is most often cited by research in Immunology and Allergy (95 citations), Pulmonary and Respiratory Medicine (464 citations), Nutrition and Dietetics (130 citations), Immunology (156 citations) and Biochemistry (54 citations). Olaf Eickmeier has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Stefan Zielen, Ralf Schubert, Martin Rosewich, Sabina Schmitt‐Grohé, Patrick C. Baer, Eva Herrmann, Christina Smaczny, Ulrich M. Zissler, Jan N. Hilberath and Markus Andreas Rose. Their work appears in journals such as Journal of Cystic Fibrosis, European Respiratory Journal, Frontiers in Bioscience-Landmark, Mucosal Immunology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.